NMTRQ
vs
JNJ
NMTRQ
JNJ
Over the past 12 months, NMTRQ has underperformed JNJ, delivering a return of 0% compared to the JNJ's +57% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
NMTRQ
JNJ
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
9 Meters Biopharma Inc
OTC:NMTRQ
|
0.0001
USD
|
|||||
|
Johnson & Johnson
NYSE:JNJ
|
243.59
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
NMTRQ, JNJ
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
9 Meters Biopharma Inc
Revenue
|
|||||||||||
|
Johnson & Johnson
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
NMTRQ, JNJ
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
9 Meters Biopharma Inc
OTC:NMTRQ
|
|||||||||
|
Johnson & Johnson
NYSE:JNJ
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
9 Meters Biopharma Inc | ||||
|
Johnson & Johnson | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
NMTRQ, JNJ
Performance By Year
NMTRQ, JNJ
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|